vs
Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and RXO, Inc. (RXO). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× RXO, Inc.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -3.1%, a 7.6% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -11.9%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-9.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 26.8%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.
ONC vs RXO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.5B |
| Net Profit | $66.5M | $-46.0M |
| Gross Margin | 90.5% | — |
| Operating Margin | 12.4% | -2.9% |
| Net Margin | 4.4% | -3.1% |
| Revenue YoY | 32.8% | -11.9% |
| Net Profit YoY | 143.8% | -84.0% |
| EPS (diluted) | $0.05 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.0B | $1.0B | ||
| Q2 24 | $929.2M | $930.0M | ||
| Q1 24 | $751.7M | $913.0M |
| Q4 25 | $66.5M | $-46.0M | ||
| Q3 25 | $124.8M | $-14.0M | ||
| Q2 25 | $94.3M | $-9.0M | ||
| Q1 25 | $1.3M | $-31.0M | ||
| Q4 24 | $-151.9M | $-25.0M | ||
| Q3 24 | $-121.3M | $-243.0M | ||
| Q2 24 | $-120.4M | $-7.0M | ||
| Q1 24 | $-251.2M | $-15.0M |
| Q4 25 | 90.5% | — | ||
| Q3 25 | 86.1% | — | ||
| Q2 25 | 87.5% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 85.1% | — | ||
| Q1 24 | 83.4% | — |
| Q4 25 | 12.4% | -2.9% | ||
| Q3 25 | 11.5% | -0.5% | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 1.0% | -2.1% | ||
| Q4 24 | -7.0% | -1.4% | ||
| Q3 24 | -12.0% | -1.9% | ||
| Q2 24 | -11.5% | — | ||
| Q1 24 | -34.8% | -1.3% |
| Q4 25 | 4.4% | -3.1% | ||
| Q3 25 | 8.8% | -1.0% | ||
| Q2 25 | 7.2% | -0.6% | ||
| Q1 25 | 0.1% | -2.2% | ||
| Q4 24 | -13.5% | -1.5% | ||
| Q3 24 | -12.1% | -23.4% | ||
| Q2 24 | -13.0% | -0.8% | ||
| Q1 24 | -33.4% | -1.6% |
| Q4 25 | $0.05 | $-0.28 | ||
| Q3 25 | $0.08 | $-0.08 | ||
| Q2 25 | $0.06 | $-0.05 | ||
| Q1 25 | $0.00 | $-0.18 | ||
| Q4 24 | $-0.10 | $-0.17 | ||
| Q3 24 | $-0.09 | $-1.81 | ||
| Q2 24 | $-0.09 | $-0.06 | ||
| Q1 24 | $-0.19 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $17.0M |
| Total DebtLower is stronger | $836.4M | $387.0M |
| Stockholders' EquityBook value | $4.4B | $1.5B |
| Total Assets | $8.2B | $3.3B |
| Debt / EquityLower = less leverage | 0.19× | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $17.0M | ||
| Q3 25 | $4.0B | $25.0M | ||
| Q2 25 | $2.8B | $18.0M | ||
| Q1 25 | $2.5B | $16.0M | ||
| Q4 24 | $2.6B | $35.0M | ||
| Q3 24 | $2.7B | $55.0M | ||
| Q2 24 | $2.6B | $7.0M | ||
| Q1 24 | $2.8B | $7.0M |
| Q4 25 | $836.4M | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | — | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $351.0M |
| Q4 25 | $4.4B | $1.5B | ||
| Q3 25 | $4.1B | $1.6B | ||
| Q2 25 | $3.8B | $1.6B | ||
| Q1 25 | $3.5B | $1.6B | ||
| Q4 24 | $3.3B | $1.6B | ||
| Q3 24 | $3.4B | $1.7B | ||
| Q2 24 | $3.4B | $579.0M | ||
| Q1 24 | $3.4B | $582.0M |
| Q4 25 | $8.2B | $3.3B | ||
| Q3 25 | $7.6B | $3.2B | ||
| Q2 25 | $6.3B | $3.2B | ||
| Q1 25 | $5.8B | $3.3B | ||
| Q4 24 | $5.9B | $3.4B | ||
| Q3 24 | $5.8B | $3.4B | ||
| Q2 24 | $5.7B | $1.8B | ||
| Q1 24 | $5.7B | $1.8B |
| Q4 25 | 0.19× | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $417.3M | $7.0M |
| Free Cash FlowOCF − Capex | $379.8M | $-9.0M |
| FCF MarginFCF / Revenue | 25.4% | -0.6% |
| Capex IntensityCapex / Revenue | 2.5% | 1.1% |
| Cash ConversionOCF / Net Profit | 6.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $941.7M | $-8.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $417.3M | $7.0M | ||
| Q3 25 | $402.6M | $23.0M | ||
| Q2 25 | $263.6M | $23.0M | ||
| Q1 25 | $44.1M | $-2.0M | ||
| Q4 24 | $75.2M | $-7.0M | ||
| Q3 24 | $188.4M | $-7.0M | ||
| Q2 24 | $-95.6M | $-5.0M | ||
| Q1 24 | $-308.6M | $7.0M |
| Q4 25 | $379.8M | $-9.0M | ||
| Q3 25 | $354.5M | $9.0M | ||
| Q2 25 | $219.8M | $9.0M | ||
| Q1 25 | $-12.3M | $-17.0M | ||
| Q4 24 | $-17.3M | $-19.0M | ||
| Q3 24 | $54.7M | $-18.0M | ||
| Q2 24 | $-205.5M | $-16.0M | ||
| Q1 24 | $-465.1M | $-4.0M |
| Q4 25 | 25.4% | -0.6% | ||
| Q3 25 | 25.1% | 0.6% | ||
| Q2 25 | 16.7% | 0.6% | ||
| Q1 25 | -1.1% | -1.2% | ||
| Q4 24 | -1.5% | -1.1% | ||
| Q3 24 | 5.5% | -1.7% | ||
| Q2 24 | -22.1% | -1.7% | ||
| Q1 24 | -61.9% | -0.4% |
| Q4 25 | 2.5% | 1.1% | ||
| Q3 25 | 3.4% | 1.0% | ||
| Q2 25 | 3.3% | 1.0% | ||
| Q1 25 | 5.0% | 1.0% | ||
| Q4 24 | 8.2% | 0.7% | ||
| Q3 24 | 13.3% | 1.1% | ||
| Q2 24 | 11.8% | 1.2% | ||
| Q1 24 | 20.8% | 1.2% |
| Q4 25 | 6.28× | — | ||
| Q3 25 | 3.22× | — | ||
| Q2 25 | 2.79× | — | ||
| Q1 25 | 34.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONC
Segment breakdown not available.
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
